Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XASNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.3.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.3.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.3.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BE.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.4.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.1.4.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BE.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
CH.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CH.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.53NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.53NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.53NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BL.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BL.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BL.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BL.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.3.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.3.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.7NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.7NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BE.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BE.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BQ.1.1.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.9NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.9NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BQ.1.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.9NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.11.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.11.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BF.11.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BF.11.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used